Cargando…

Two cases of cavitary lung cancer with concomitant chronic infectious disease

The existence of a lung cavity on chest radiographs suggests the presence of lung disease, including benign or malignant disease. Lung cancer, tuberculosis, and fungal infection are all known for developing lung cavity. In addition, there are some characteristic findings in the differential diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujita, Kohei, Uchida, Naohiro, Horimoto, Kanna, Hashimoto, Masayuki, Nakatani, Koichi, Moriyoshi, Koki, Sawai, Satoru, Mio, Tadashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6010638/ https://www.ncbi.nlm.nih.gov/pubmed/29977778 http://dx.doi.org/10.1016/j.rmcr.2018.05.010

Ejemplares similares

Coexisting Thymic and Pulmonary Carcinoid Tumors Associated with Multiple Endocrine Neoplasia Type1
por: Motoishi, Makoto, et al.
Publicado: (2017)

Nivolumab‐induced severe acute kidney injury with a long latent phase in a patient with non‐small‐cell lung cancer: A case report
por: Uchida, Naohiro, et al.
Publicado: (2018)

Incidence of Active Tuberculosis in Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
por: Fujita, Kohei, et al.
Publicado: (2020)

Acute progression of aspergillosis in a patient with lung cancer receiving nivolumab
por: Uchida, Naohiro, et al.
Publicado: (2017)

Small cell transformation of non‐small cell lung cancer under immunotherapy: Case series and literature review
por: Imakita, Takuma, et al.
Publicado: (2021)

Retreatment with anti‐PD‐1 antibody in non‐small cell lung cancer patients previously treated with anti‐PD‐L1 antibody
por: Fujita, Kohei, et al.
Publicado: (2019)

Natural course of pulmonary hyalinizing granuloma over a decade
por: Fujita, Kohei, et al.
Publicado: (2022)

Effect of cyclooxygenase inhibitor use on immunotherapy efficacy in non‐small cell lung cancer
por: Kanai, Osamu, et al.
Publicado: (2021)

Efficacy and safety of immune checkpoint inhibitors in patients with non‐small cell lung cancer aged 80 years or older
por: Saito, Zentaro, et al.
Publicado: (2021)

The clinical benefits of immune checkpoint inhibitor for thymic carcinomas ∼experience of single public hospital in Japan∼
por: Uchida, Naohiro, et al.
Publicado: (2018)

Acute onset of ulcerative colitis during chemoradiotherapy for anaplastic lymphoma kinase‐positive lung adenocarcinoma
por: Fujita, Kohei, et al.
Publicado: (2017)

Pleural involvement of diffuse large B-cell lymphoma mimicking malignant pleural mesothelioma
por: Ito, Takanori, et al.
Publicado: (2020)

A case of pulmonary lymphoproliferative disorder presenting rapidly progressive respiratory failure
por: Fujita, Kohei, et al.
Publicado: (2019)

Concurrence of nivolumab‐induced interstitial lung disease and cancer invasion
por: Kanai, Osamu, et al.
Publicado: (2017)

Therapy‐related acute myeloid leukemia after chemotherapy in extensive disease‐small cell lung cancer
por: Ueda, Naoko, et al.
Publicado: (2018)

Repetitive responses to nanoparticle albumin‐bound paclitaxel and carboplatin in malignant pleural mesothelioma
por: Kanai, Osamu, et al.
Publicado: (2016)

Postoperative delirium after lung resection for primary lung cancer: Risk factors, risk scoring system, and prognosis
por: Hayashi, Kazuki, et al.
Publicado: (2019)

De Novo SCLC Transformation From KRAS G12C-Mutated Lung Adenocarcinoma With Excellent Response to Sotorasib: A Case Report
por: Ito, Takanori, et al.
Publicado: (2023)

Development of Mycobacterium avium Complex Lung Disease in Patients With Lung Cancer on Immune Checkpoint Inhibitors
por: Fujita, Kohei, et al.
Publicado: (2020)

Simultaneous regression of non‐small cell lung cancer and orbital extranodal marginal zone lymphoma with chemoradiotherapy for lung cancer
por: Oi, Issei, et al.
Publicado: (2023)

Rapidly progressive sarcomatoid malignant mesothelioma of the pleura mimicking pulmonary empyema
por: Fujita, Kohei, et al.
Publicado: (2015)

Nasogastric tube‐administered alectinib achieved long‐term survival in a crizotinib‐refractory nonsmall cell lung cancer patient with a poor performance status
por: Kanai, Osamu, et al.
Publicado: (2017)

Impact of COVID‐19 pandemic on lung cancer treatment scheduling
por: Fujita, Kohei, et al.
Publicado: (2020)

Afebrile tension pyopneumothorax due to anaerobic bacteria: Fistula or gas production?
por: Kanai, Osamu, et al.
Publicado: (2021)

No need to hesitate: immune‐related neutropenia and thrombocytopenia that improved by corticosteroids
por: Kanai, Osamu, et al.
Publicado: (2021)

Primary Pulmonary Malignant Melanoma Successfully Treated with Immunotherapy in a 90-Year-Old Patient
por: Fujita, Kohei, et al.
Publicado: (2022)

Giant mature teratoma in the mediastinum presenting with rapid growth
por: Fujita, Kohei, et al.
Publicado: (2016)

Successful management of a lung cancer patient harbouring both EGFR mutation and EML4-ALK fusion gene with disseminated intravascular coagulation
por: Fujita, Kohei, et al.
Publicado: (2021)

Left upper division segmentectomy with a simultaneous displaced bronchus and pulmonary arteriovenous anomalies: a case report
por: Hayashi, Kazuki, et al.
Publicado: (2018)

Impact of the COVID-19 pandemic on the trajectory of the number of bronchoscopies performed in a tertiary hospital in Kyoto city
por: Fujita, Kohei, et al.
Publicado: (2023)

Aggressive Cystic and Cavitary Appearances in Lung Adenocarcinoma
por: Sasaki, Tomoya, et al.
Publicado: (2017)

Concomitant T790M mutation and small‐cell lung cancer transformation after acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor
por: Fujita, Kohei, et al.
Publicado: (2016)

Asymptomatic pulmonary cryptococcosis presenting with mixed lesions of infiltrative and nodular shadow in an immunocompromised patient
por: Ito, Takanori, et al.
Publicado: (2022)

Re-immunotherapy with nivolumab plus ipilimumab in advanced non-small cell lung cancer patients previously treated with anti-programmed death-1 and/or anti-programmed death ligand-1 antibodies
por: Imakita, Takuma, et al.
Publicado: (2023)

Beware of the master masquerader- A case series of cavitary lung disease with hearing loss
por: Vinay, V, et al.
Publicado: (2023)

Differential Diagnosis of Cavitary Lung Lesions
por: Parkar, Anagha P., et al.
Publicado: (2016)

Cavitary Lung Metastases in Prostate Cancer
por: Delbare, Felix, et al.
Publicado: (2022)

COVID-19 and Cavitary Lesion in Lung
por: Vangara, Avinash, et al.
Publicado: (2023)

Choroidal Cavitary Disorders
por: Nassar, Sandra, et al.
Publicado: (2020)

Diffuse goitre enlargement after immunotherapy for non‐small cell lung cancer
por: Fujita, Kohei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hrhuvkdnga68l4tcju9fhkcsq6